Analyst Price Target is $673.50
▲ +14.83% Upside Potential
This price target is based on 2 analysts offering 12 month price targets for Chemed in the last 3 months. The average price target is $673.50, with a high forecast of $697.00 and a low forecast of $650.00. The average price target represents a 14.83% upside from the last price of $586.53.
Current Consensus is
Buy
The current consensus among 2 investment analysts is to buy stock in Chemed. This Buy consensus rating has held steady for over two years.
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees. The company was incorporated in 1970 and is headquartered in Cincinnati, Ohio.
Read More